# PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

> **NCT06979921** · — · ACTIVE_NOT_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 496 (actual)

## Conditions studied

- Cancer

## Interventions

- **DEVICE:** Blood test

## Key facts

- **NCT ID:** NCT06979921
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-07-10
- **Primary completion:** 2023-05-31
- **Final completion:** 2026-12-30
- **Target enrollment:** 496 (ACTUAL)
- **Last updated:** 2025-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06979921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06979921, "PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06979921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*